SURGICAL INNOVATIONS GROUP PLC
GRANTS OF OPTIONS
Surgical Innovations Group plc ("the Company") announces that on 27 January
2009 the Company granted options to subscribe for 8,000,000 ordinary shares of
1p each to directors and employees of the Company. All of the options are
exerciseable at a price of 1.5p per share at any time between 27 January 2012
and 27 January 2019.
Options granted to the directors of the Company are as follows:
Director Number of options granted
Douglas Liversidge 1,000,000
Graham Bowland 2,000,000
Colin Glass 1,000,000
Ray Simkins 1,000,000
Professor Michael J McMahon 1,000,000
Following the grant of options, there are 33,200,000 options in issue over
ordinary shares in the Company, representing 8.9 per cent. of the current
issued share capital. The options are exerciseable at prices between 1.5p and
3.5p per share.
Enquiries:
Surgical Innovations Group plc 07715 612063
Graham Bowland
Hanson Westhouse Limited 0113 246 2610
Tim Feather / Matthew Johnson
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.